Manufacturing AbbVie makes record investment in North Carolina plant PharmaphorumAbbVie's $100bn programme of facility investments in the US has continued with a new 185-acre campus in Durham, North Carolina.ManufacturingRead full story pharminent April 23, 2026 (Last updated: April 23, 2026) Pharmaphorum AbbVie’s $100bn programme of facility investments in the US has continued with a new 185-acre campus in Durham, North Carolina. ManufacturingRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: FDA Releases Congressional Justification for FY 2027 Budget, Including Proposal Regarding Interchangeability of BiosimilarsNext: MSD teams up with Google Cloud on agentic AI transformation Related Stories Manufacturing FDA Warning Letter Hits Sanofi’s Genzyme Ireland Site pharminent July 8, 2026 Manufacturing Tanabe pens deal to sell plants to Towa in post-buyout pivot pharminent July 8, 2026 Manufacturing FDA Selects Seven for PreCheck Pilot to Advance Drug Manufacturing pharminent July 1, 2026
